Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence

Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities.